Notice for epcoritamab (Abbvie Pty Ltd)
Active ingredients
epcoritamab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for injection
Indication
Treatment of patients with diffuse large B cell lymphoma (DLBCL)
Therapeutic area
Haematology